Skip to search formSkip to main contentSkip to account menu

sabcomeline

Known as: alpha-(methylimino)-1-azabicyclo(2.2.2)octane-3-acetonitrile 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2010
Review
2010
The limited effect of AChE inhibitors and NMDA receptor antagonists for the treatment of the cognitive symptoms of Alzheimer's… 
Highly Cited
2009
Highly Cited
2005
Highly Cited
2005
Prepulse inhibition (PPI) of the acoustic startle reflex is a sensorimotor gating process known to be deficient in a number of… 
2001
2001
  • P. StengelM. Cohen
  • The Journal of pharmacology and experimental…
  • 2001
  • Corpus ID: 31263878
Carbamylcholine, a nonselective muscarinic receptor agonist, and sabcomeline and xanomeline, functional M(1) receptor-selective… 
Highly Cited
1999
Highly Cited
1999
This study describes the pharmacological comparison of the muscarinic partial agonists sabcomeline, xanomeline and milameline at… 
1999
1999
Research into and development of selective muscarinic receptor agonists for the treatment of Alzheimer’s disease is based on the… 
1998
1998
Abstract Sabcomeline, (SB-202026 [R-(Z)-α-(methoxyimino)-1-azabicyclo [2.2.2] octane-3-acetonitrile]), a functionally selective… 
1998
1998
Sabcomeline (SB‐202026, 0.03 mg kg−1, p.o.), a potent and functionally selective M1 receptor partial agonist, caused a…